Dr Sunir Garg explores how AI is transforming retinal care, from individualized treatments to tracking disease progression and bridging gaps across specialties. Medscape
Uncategorized
Aflibercept, faricimab show treatment interval extension, safety
NEW YORK — Real-world data demonstrated an extension of treatment intervals and positive safety results for aflibercept 8 mg and faricimab when used to manage retinal diseases, according to a presenter.At the OSN New York Retina meeting, Rishi P. Singh…
Uncategorized
VIDEO: Tyrosine kinase inhibitors, gene therapy being investigated for wet AMD
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Esther M. Bowie, MD, discusses what is “new and exciting” in wet age-related macular degeneration.Tyrosine kinase inhibitors being investigated for wet AMD include EYP-1901 (vo…
Indigenous Canadians Face Barriers to Adequate Eye Care
Vision care for Canada’s Indigenous population is marked by the absence of early disease detection, accessible services, and a national eye care strategy. Medscape News Canada
Uncategorized
Antibody-mediated optic neuritis requires different approach
NEW YORK — For optic neuritis management, ophthalmologists must learn how to diagnose and treat antibody-mediated forms of the disease, according to a presenter.“You need to know about two new kids on the block: antibody-mediated myelin oligodendrocyte…
Uncategorized
Secondary techniques needed for myopic macular holes
NEW YORK — Secondary techniques are needed to address macular holes in patients with myopia, according to a speaker at OSN New York Retina.Christina Y. Weng, MD, MBA, FASRS, said myopia has reached epidemic proportions, and it is increasing in prevalen…